Project Details
Description
This 26-week double-blind, placebo-controlled, multicenter clinical trial will determine if the addition of Troglitazone, an oral medication, can decrease or eliminate the need for insulin in NIDDM patients taking insulin.
| Status | Finished |
|---|---|
| Effective start/end date | 1/10/97 → 30/09/99 |
Funding
- National Center for Research Resources
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.